Literature DB >> 30689792

Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation.

Matthew P Cheng1,2,3, Amanda E Kusztos1,2, Tyler D Bold1,3,4, Vincent T Ho2,3, Brett E Glotzbecker2,3, Candace Hsieh2, Meghan A Baker1,2,3, Lindsey R Baden1,2,3, Sarah P Hammond1,2,3, Francisco M Marty1,2,3.   

Abstract

There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0-0.05 cases/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0-4.06 cases/100 person-years).
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Mycobacterium tuberculosiszzm321990 ; LTBI; TB; allogeneic; hematopoietic cell transplantation

Mesh：

Substances：

Year:  2019        PMID： 30689792      PMCID： PMC6938207          DOI： 10.1093/cid/ciz048

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  Matthew P Cheng; Claire Nour Abou Chakra; Cedric P Yansouni; Sonya Cnossen; Ian Shrier; Dick Menzies; Christina Greenaway
Journal:  Clin Infect Dis       Date:  2016-12-16       Impact factor: 9.079

2.  Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.

Authors:  Dick Menzies; Menonli Adjobimey; Rovina Ruslami; Anete Trajman; Oumou Sow; Heejin Kim; Joseph Obeng Baah; Guy B Marks; Richard Long; Vernon Hoeppner; Kevin Elwood; Hamdan Al-Jahdali; Martin Gninafon; Lika Apriani; Raspati C Koesoemadinata; Afranio Kritski; Valeria Rolla; Boubacar Bah; Alioune Camara; Isaac Boakye; Victoria J Cook; Hazel Goldberg; Chantal Valiquette; Karen Hornby; Marie-Josée Dion; Pei-Zhi Li; Philip C Hill; Kevin Schwartzman; Andrea Benedetti
Journal:  N Engl J Med       Date:  2018-08-02       Impact factor: 91.245

3.  Tuberculosis morbidity in the U.S. Navy: its distribution and decline.

Authors:  G W Comstock; L B Edwards; V T Livesay
Journal:  Am Rev Respir Dis       Date:  1974-11

4.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-11-01       Impact factor: 21.405

5.  Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation.

Authors:  Narendra Agrawal; Mukul Aggarwal; Jyotsna Kapoor; Rayaz Ahmed; Anjan Shrestha; Meena Kaushik; Dinesh Bhurani
Journal:  Transpl Infect Dis       Date:  2017-11-26       Impact factor: 2.228

6.  Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.

Authors:  W-C Fan; C-J Liu; Y-C Hong; J-Y Feng; W-J Su; S-H Chien; T-J Chen; C-H Chiang
Journal:  Int J Tuberc Lung Dis       Date:  2015-01       Impact factor: 2.373

7.  Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: A cohort study in a high endemic area.

Authors:  Yao-Chung Liu; Chi-Jung Wu; Po-Shen Ko; Sheng-Hsuan Chien; Nai-Wen Fan; Hao-Yuan Wang; Jyh-Pyng Gau; Chia-Jen Liu; Liang-Tsai Hsiao; Tzeon-Jye Chiou; Chun-Yu Liu; Jin-Hwang Liu
Journal:  J Microbiol Immunol Infect       Date:  2018-07-26       Impact factor: 4.399

8.  Revisiting the timetable of tuberculosis.

Authors:  Marcel A Behr; Paul H Edelstein; Lalita Ramakrishnan
Journal:  BMJ       Date:  2018-08-23

9.  Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.

Authors:  Ibrahim Abubakar; Francis Drobniewski; Jo Southern; Alice J Sitch; Charlotte Jackson; Marc Lipman; Jonathan J Deeks; Chris Griffiths; Graham Bothamley; William Lynn; Helen Burgess; Bobby Mann; Ambreen Imran; Saranya Sridhar; Chuen-Yan Tsou; Vladyslav Nikolayevskyy; Melanie Rees-Roberts; Hilary Whitworth; Onn Min Kon; Pranab Haldar; Heinke Kunst; Sarah Anderson; Andrew Hayward; John M Watson; Heather Milburn; Ajit Lalvani
Journal:  Lancet Infect Dis       Date:  2018-08-30       Impact factor: 71.421

Review 10.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069
  10 in total
  6 in total

1.  A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients.

Authors:  Andrea Sosa-Moreno; Masahiro Narita; Christopher Spitters; Michelle Swetky; Sara Podczervinski; Margaret L Lind; Leona Holmberg; Catherine Liu; Raleigh Edelstein; Steven A Pergam
Journal:  Open Forum Infect Dis       Date:  2020-06-10       Impact factor: 3.835

2.  Identification and Treatment of Tuberculosis in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Review of the Literature.

Authors:  Xiaodong Wang; Uet Yu; Xiaonan Li; Chunjing Wang; Qian Zhang; Chunlan Yang; Xiaoling Zhang; Yu Zhang; Ying Wang; Yuejie Zheng; Jikui Deng; Weiguo Yang; Guosheng Liu; Guofang Deng; Sixi Liu; Feiqiu Wen
Journal:  Infect Drug Resist       Date:  2020-07-31       Impact factor: 4.003

3.  Is Mycobacterium tuberculosis infection life long?

Authors:  Marcel A Behr; Paul H Edelstein; Lalita Ramakrishnan
Journal:  BMJ       Date:  2019-10-24

4.  Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014.

Authors:  Joumana Kmeid; Prathit A Kulkarni; Marjorie V Batista; Firas El Chaer; Amrita Prayag; Ella J Ariza-Heredia; Victor E Mulanovich; Roy F Chemaly
Journal:  BMC Infect Dis       Date:  2019-11-06       Impact factor: 3.090

5.  Disseminated Tuberculosis with Cholecystitis in a Patient after Cord Blood Transplantation.

Authors:  Takaaki Konuma; Masamichi Isobe; Eisuke Adachi; Seiko Kato; Satoshi Takahashi; Hiroshi Yotsuyanagi; Arinobu Tojo
Journal:  Intern Med       Date:  2020-07-14       Impact factor: 1.271

6.  Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome.

Authors:  Mirko Compagno; Assunta Navarra; Laura Campogiani; Luigi Coppola; Benedetta Rossi; Marco Iannetta; Vincenzo Malagnino; Saverio G Parisi; Benedetta Mariotti; Raffaella Cerretti; William Arcese; Delia Goletti; Massimo Andreoni; Loredana Sarmati
Journal:  Int J Environ Res Public Health       Date:  2022-08-27       Impact factor: 4.614
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.